<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have established three <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines, HF-1 from one follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) patient, and HF-4 and HF-9 from another </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> cell lines carry the characteristic t(14;18) chromosomal translocation and express constitutively the bcl-2 gene product (Bcl-2 protein) </plain></SENT>
<SENT sid="2" pm="."><plain>Cross-linking of their surface membrane Igs (sIgs) with relevant antibodies triggers a vigorous calcium signal in <z:hpo ids='HP_0000001'>all</z:hpo> three lines but only HF-1 is induced to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment with anti-Ig arrests the proliferation of HF-1 within 6-12 h, nucleosomal DNA fragmentation is evident in 18 h and a morphologically complete <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is seen in 24-48 h </plain></SENT>
<SENT sid="4" pm="."><plain>While bcl-2 was expressed at equal levels in <z:hpo ids='HP_0000001'>all</z:hpo> lines, the <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-sensitive HF-1 line displayed a much lower expression of c-myc than seen in the <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-resistant line </plain></SENT>
<SENT sid="5" pm="."><plain>This finding challenges the concept that expression of bcl-2 per se renders resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> but that the balance between the expression of bcl-2 and c-myc may dictate the outcome of sIg cross-linking </plain></SENT>
<SENT sid="6" pm="."><plain>HF-1 is a unique, phenotypically mature human B cell line expressing surface IgG </plain></SENT>
<SENT sid="7" pm="."><plain>This cell line offers a new tool for investigations on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and induction of tolerance in mature B lymphocytes </plain></SENT>
<SENT sid="8" pm="."><plain>Our results suggest that some FLs may be amenable to anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatment based on anti-sIg antibody induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>